Dr. Cho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
92 2nd Street
Hackensack, NJ 07601Phone+1 551-996-8297Fax+1 551-996-0575
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 2014
Columbia University Vagelos College of Physicians and SurgeonsClass of 2011
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology
Certifications & Licensure
CA State Medical License 2013 - Present
NJ State Medical License 2022 - 2025
NY State Medical License 2014 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Publications & Presentations
PubMed
- Five-Year Real-World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B-Cell Precursor Acute Lymphoblastic Leukemia.Marcos de Lima, Partow Kebriaei, Francesco Lanza, Christina Cho, Gizelle Popradi
American Journal of Hematology. 2025-02-24 - Health-Related Values Discussions with Patients Undergoing Allogeneic and Autologous Stem Cell Transplant: Feasibility and Acceptability of an Early Primary Palliative...Abigail G Cohen, Christina Cho, Emily Patterson, Jessica Magaldi, Tara Doga
Transplantation and Cellular Therapy. 2025-02-01 - Comprehensive Review of Early and Late Toxicities in CAR T-Cell Therapy and Bispecific Antibody Treatments for Hematologic Malignancies.Ayrton Bangolo, Behzad Amoozgar, Charlene Mansour, Lili Zhang, Sarvarinder Gill
Cancers. 2025-01-17
Abstracts/Posters
- Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell TransplantationChristina Cho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First RemissionClinically Relevant AbstractChristina Cho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
